Home › Funds › Ikarian Capital, LLC › ANRO
Ikarian Capital, LLC position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Ikarian Capital, LLC reported holding 482,338 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 1.81% of its reported portfolio and ranking #12 among its reported holdings. Ikarian Capital, LLC has disclosed ANRO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's ANRO position evolved
Ikarian Capital, LLC first disclosed a stake in ANRO in Q3 2024 at 431,000 shares (US$4.9M). The position peaked in Q3 2026 at 482,338 shares, worth US$12.3M. Across 9 filings, Ikarian Capital, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 482,338 shares valued at US$12.3M — an increase of 75,000 shares quarter over quarter.. Notable position changes include a 50% trim in Q1 2025 (shares rose 2% over the following quarter), a 37% trim in Q2 2025 (shares rose 83% over the following quarter), a 368% increase in Q4 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 431.00K | $4.93M | New |
| Q4 2024 | 350.00K | $1.48M | Reduce |
| Q1 2025 | 175.00K | $378.00K | Reduce |
| Q2 2025 | 110.00K | $242.00K | Reduce |
| Q3 2025 | 110.00K | $442.20K | Hold |
| Q4 2025 | 515.00K | $9.17M | Add |
| Q1 2026 | 515.00K | $11.58M | Hold |
| Q2 2026 | 407.34K | $10.75M | Reduce |
| Q3 2026 | 482.34K | $12.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANRO and 13F data
ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 60 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$94.7M), Commodore Capital LP (US$69.5M), EcoR1 Capital, LLC (US$57.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANRO
- Alpha Wave Global, LP 3.71M sh · $94.66M · Q3 2026
- Commodore Capital LP 2.72M sh · $69.52M · Q3 2026
- EcoR1 Capital, LLC 2.23M sh · $56.98M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.76M sh · $44.96M · Q3 2026
- Spruce Street Capital LP 1.68M sh · $42.80M · Q3 2026
- Vivo Capital, LLC 1.36M sh · $34.72M · Q3 2026
- Bellevue Group AG 1.16M sh · $29.71M · Q3 2026
- Parkman Healthcare Partners LLC 948.86K sh · $24.22M · Q3 2026
- 72 Investment Holdings, LLC 667.78K sh · $17.05M · Q3 2026
- Affinity Asset Advisors, LLC 643.34K sh · $16.42M · Q3 2026
- Saturn V Capital Management LP 518.11K sh · $13.23M · Q3 2026
- Integral Health Asset Management, LLC 500.00K sh · $12.77M · Q3 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held ANRO?
Ikarian Capital, LLC has disclosed ANRO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Ikarian Capital, LLC's current position in ANRO?
As of Q3 2026, Ikarian Capital, LLC holds 482.34K shares of ANRO (ALTO NEUROSCIENCE INC), valued at $12.31M, representing 1.81% of its reported portfolio and ranking #12.
Has Ikarian Capital, LLC been buying or selling ANRO?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC increased its position in ANRO. The position peaked in Q3 2026 at 482.34K shares.
Which other funds hold ANRO?
Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, EcoR1 Capital, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.